Jobs
-
According to intranasal drug developer Impel NeuroPharma, the company has signed service agreements with 505(b)(2) development specialist Camargo Pharmaceutical Services. Camargo will provide development services for products based on Impel’s Precision Olfactory Delivery (PODTM) intranasal… Read more . . .
-
Inhaler testing equipment company Copley Scientific will more than double the size of its headquarters in Colwick, Nottingham, UK, the company has announced. Construction on the new building is expected to be complete by the… Read more . . .
-
According to Spyryx Biosciences, a Phase 1 study of its SPX-101, an inhaled SPLUNC1-derived peptide that the company is developing for the treatment of cystic fibrosis, showed that the drug was well tolerated, with no… Read more . . .
-
Oxford Lasers has announced that it will be able to supply its EnVision spray characterization system in Europe following a decision in its favor by the European Patent Office Board of Appeal. The decision revoked… Read more . . .
-
MannKind Corporation has announced the availability of a new titration pack which includes 60 each of 4, 8, and 12 unit cartridges of Afrezza inhalation powder. The company already offers a titration pack that includes… Read more . . .
-
Noveome Biotherapeutics has announced the publication of promising data from a preclinical study of its ST266 intranasal secretome showing anti-inflammatory activity and retinal ganglion cell (RGC) retention in the optic nerve in a mouse multiple… Read more . . .
-
The FDA has accepted OptiNose’s new drug application for its OPN-375 intranasal fluticasone for the treatment of nasal polyposis in adult patients, with an anticipated PDUFA date in September 2017, the company announced. OptiNose CEO… Read more . . .
-
Q: What benefits are offered by extrafine particles? A: There is growing evidence to suggest that finer aerosols may enable us to effectively direct particles into more efficacious areas of the lung and to achieve a… Read more . . .
-
Bangladeshi generics company Beximco Pharmaceuticals announced that it has entered into a joint venture with Malaysian pharma company BioCare and said that the first joint project, an MDI manufacturing facility in Seri Iskandar Pharmaceutical Park,… Read more . . .
-
Inhaled drug developer Pulmatrix has announced an agreement to sell approximately 2 million shares of its common stock to institutional investors at $2.50 per share in a registered direct offering expected to generate net proceeds… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland